PRISTIQ ER 50 MG TABLET

desvenlafaxine succinate
$13.2311per EA
High Outlier

Strength

50 mg/1

NDC

00008121150

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

1/1/2020

Active Ingredients

DESVENLAFAXINE SUCCINATE

Approval Type

New Drug (NDA)

FDA Application

NDA021992

On Market Since

5/1/2008

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+130.5%